Depleting SLAMF6 improved CD8+ T cells in the short and long-term, as was most evident when the WT Pmel-1 cells induced the regression of melanoma only for a limited period while the Pmel-1 x SLAMF6 -/- cells led to lasting responses in mice (Figure 4H). This evidence concerns the gene SLAMF6 and melanoma.